Sutro Biopharma Inc.

1.45
-0.14 (-8.81%)
At close: Mar 03, 2025, 3:59 PM
1.50
3.81%
After-hours: Mar 03, 2025, 04:06 PM EST

Sutro Biopharma Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 153.73M 67.77M 61.88M 42.72M 42.74M 38.42M 51.74M 59.73M
Cost of Revenue 6.82M 8.29M 9.77M 76.96M 65.61M 54.26M 51.9M 43.55M
Gross Profit 146.91M 59.48M 52.11M -34.24M -22.88M -15.84M -156K 16.18M
Operating Income -89.28M -128.94M -98.52M -71.06M -55.47M -37.22M -19.27M 1.36M
Interest Income 14.51M 3.46M 577K 1.51M 4.07M 1.62M 273K 251K
Pretax Income -88.6M -116.7M -105.54M -32.13M -55.74M -35.32M -19.69M 1.7M
Net Income -106.79M -119.2M -108.67M -36.2M -55.74M -35.32M -19.69M 1.7M
Selling & General & Admin 62.58M 59.54M 56M 36.82M 32.59M 21.38M 16.37M 14.82M
Research & Development 180.43M 137.17M 104.4M 76.96M 65.61M 54.26M 54.64M 43.55M
Other Expenses n/a n/a n/a n/a -4.35M 1.91M -77K 87K
Operating Expenses 243.01M 196.72M 160.4M 113.78M 98.2M 75.64M 71.01M 58.37M
Interest Expense 23.75M 3.35M 3.14M 4.08M 4.35M 1.62M 612K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 243.01M 196.72M 160.4M 113.78M 98.2M 75.64M 71.01M 58.37M
Income Tax 18.19M 2.5M 3.14M 4.08M 8.68M 3.53M 535K 87K
Shares Outstanding (Basic) 60.16M 50.74M 46.12M 32.57M 22.96M 5.76M 7M 7M
Shares Outstanding (Diluted) 60.16M 50.74M 46.12M 32.57M 22.96M 5.76M 7M 7M
EPS (Basic) -1.78 -2.35 -2.36 -1.11 -2.43 -6.13 -2.81 0.24
EPS (Diluted) -1.78 -2.35 -2.36 -1.11 -2.43 -6.13 -2.81 0.24
EBITDA -67.92M -105.07M -98.52M -23.75M -46.62M -32.82M -14.09M 7.36M
Depreciation & Amortization 6.82M 8.29M 9.77M 4.3M 4.78M 4.54M 4.99M 5.66M